Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by 2Xideas AG

2Xideas AG cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 14,472 shares of the medical equipment provider’s stock after selling 2,778 shares during the period. 2Xideas AG’s holdings in Intuitive Surgical were worth $7,554,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at about $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical in the 4th quarter valued at about $82,517,000. Sycomore Asset Management boosted its holdings in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after buying an additional 4,079 shares during the last quarter. Exome Asset Management LLC increased its stake in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its stake in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 8.7 %

NASDAQ ISRG opened at $451.58 on Friday. The stock has a market cap of $160.84 billion, a price-to-earnings ratio of 70.45, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The business has a fifty day moving average of $545.18 and a 200-day moving average of $532.64.

Analyst Ratings Changes

ISRG has been the topic of several research reports. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Bernstein Bank raised their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Erste Group Bank downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Evercore ISI upped their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $611.86.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.70% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.